Why Your Financial Future Could Change Forever Tomorrow

0 | By Wall Street Insights and Indictments Staff

Back in June, we told you about the beginning of the second wave of medical marijuana.

This wave was triggered by the first ever FDA-approved cannabis-based drug, Epidiolex, which was created by GW Pharmaceuticals plc (NasdaqGM:GWPH).

In short, this green light from the government could be the initial spark to light the fire for the next wave of “marijuana millionaires.”

But the good news is that the profit potential doesn’t end there.

If you’ve had any doubts or qualms with the marijuana industry, if you want to learn more about it before jumping in, or if you’re not sure how to break into such a lucrative market… We have a huge opportunity for you.

Tomorrow, Tuesday, October 23, something huge is happening… And you’re going to want to be there for it

Is the Upcoming Uber IPO Worth the Ride?

0 | By Shah Gilani

Last week Uber kind of, sort of announced it was going to go public in early 2019 at a valuation of about $120 billion.

It wasn’t Uber directly saying that. It was a Wall Street Journal story that more than likely came from sources at the company.

We can assume the news really came from Uber, because the $120 billion valuation number was based on talks Uber had with potential lead underwriters The Goldman Sachs Group Inc. (NYSE:GS) and Morgan Stanley (NYSE:MS). And they wouldn’t have leaked that to the Journal. That number would have had to come from Uber itself.

And I can tell you that the answers to all these questions will kind of, sort of shock you, but there’s a potentially lucrative opportunity that could make relying on stocks obsolete…